Focus In The Biotech Sector Could Soon Turn To These Therapeutic Areas And Companies
While vaccine makers have gotten most of the attention in the biotech sector over the past year, the author of today’s article advises that other…
Biogen
Biogen’s Good News Could Be Great News For Other Biotechs Focused On Neurodegenerative Diseases
The FDA’s approval of Biogen’s Alzheimer’s drug “has set a precedent, showing a much easier path to approval for investigative drug treatments focused on neurodegenerative…
COVID & Non-COVID, 3 Biotech Stocks To Watch
Against a backdrop in which investors remain keen on COVID-19 vaccine stocks such as Moderna and Novavax, and in which Biogen has just received the…